CLINICAL_TRIALS
trial_result
· 2019-09-23
Clinical Trial Update: STudy to vAlidate telemetRic ECG Systems for firsT Dose Administration of Fingolimod (START) [Phase 4]
Summary
Phase 4 trial evaluating telemetric ECG systems for first dose administration of fingolimod in multiple sclerosis; study completed with results posted in 2019.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: Multiple Sclerosis | Phase 4 | Status: COMPLETED | Results posted: 2019-09-23